Rank | Gene Set | Z-score |
---|---|---|
1 | developmental pigmentation (GO:0048066) | 5.84059253 |
2 | tyrosine metabolic process (GO:0006570) | 5.55191795 |
3 | antigen processing and presentation of exogenous peptide antigen via MHC class I, TAP-independent (G | 5.54220478 |
4 | positive regulation by symbiont of host defense response (GO:0052509) | 5.48620312 |
5 | modulation by symbiont of host defense response (GO:0052031) | 5.48620312 |
6 | modulation by organism of immune response of other organism involved in symbiotic interaction (GO:00 | 5.48620312 |
7 | modulation by organism of defense response of other organism involved in symbiotic interaction (GO:0 | 5.48620312 |
8 | positive regulation by organism of defense response of other organism involved in symbiotic interact | 5.48620312 |
9 | modulation by symbiont of host immune response (GO:0052553) | 5.48620312 |
10 | cellular response to thyroid hormone stimulus (GO:0097067) | 5.23500897 |
11 | regulation of integrin-mediated signaling pathway (GO:2001044) | 5.00466996 |
12 | endosome to melanosome transport (GO:0035646) | 4.94118785 |
13 | endosome to pigment granule transport (GO:0043485) | 4.94118785 |
14 | secondary metabolic process (GO:0019748) | 4.84678162 |
15 | phenol-containing compound biosynthetic process (GO:0046189) | 4.79312680 |
16 | positive regulation of ryanodine-sensitive calcium-release channel activity (GO:0060316) | 4.70822644 |
17 | positive regulation of interferon-alpha production (GO:0032727) | 4.48424803 |
18 | response to peptidoglycan (GO:0032494) | 4.48057159 |
19 | neutrophil activation involved in immune response (GO:0002283) | 4.46781580 |
20 | response to thyroid hormone (GO:0097066) | 4.30356169 |
21 | macrophage activation involved in immune response (GO:0002281) | 4.29846303 |
22 | regulation of interferon-alpha production (GO:0032647) | 4.23036847 |
23 | regulation of early endosome to late endosome transport (GO:2000641) | 4.07902154 |
24 | regulation of interferon-beta biosynthetic process (GO:0045357) | 4.05153401 |
25 | actin-myosin filament sliding (GO:0033275) | 4.03110133 |
26 | muscle filament sliding (GO:0030049) | 4.03110133 |
27 | response to epinephrine (GO:0071871) | 3.87330712 |
28 | hydrogen peroxide biosynthetic process (GO:0050665) | 3.81355552 |
29 | positive regulation of interleukin-8 biosynthetic process (GO:0045416) | 3.81192144 |
30 | sarcoplasmic reticulum calcium ion transport (GO:0070296) | 3.80522049 |
31 | positive regulation of receptor recycling (GO:0001921) | 3.80151604 |
32 | melanosome organization (GO:0032438) | 3.77744568 |
33 | positive regulation of nitric-oxide synthase biosynthetic process (GO:0051770) | 3.73801839 |
34 | cGMP-mediated signaling (GO:0019934) | 3.72245350 |
35 | detection of molecule of bacterial origin (GO:0032490) | 3.71356543 |
36 | regulation of skeletal muscle contraction (GO:0014819) | 3.66971647 |
37 | myofibril assembly (GO:0030239) | 3.57937929 |
38 | response to host immune response (GO:0052572) | 3.57699912 |
39 | response to immune response of other organism involved in symbiotic interaction (GO:0052564) | 3.57699912 |
40 | regulation of cardiac muscle contraction by regulation of the release of sequestered calcium ion (GO | 3.56683631 |
41 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum (GO:0010880) | 3.55529287 |
42 | respiratory burst (GO:0045730) | 3.55465189 |
43 | * neuroepithelial cell differentiation (GO:0060563) | 3.54680229 |
44 | pigment granule organization (GO:0048753) | 3.54088589 |
45 | actin-mediated cell contraction (GO:0070252) | 3.51620798 |
46 | sarcomere organization (GO:0045214) | 3.48927748 |
47 | lipopolysaccharide-mediated signaling pathway (GO:0031663) | 3.48200161 |
48 | ketone body metabolic process (GO:1902224) | 3.48182466 |
49 | production of molecular mediator involved in inflammatory response (GO:0002532) | 3.47825954 |
50 | negative regulation of hydrogen peroxide-induced cell death (GO:1903206) | 3.42730660 |
51 | glycosphingolipid catabolic process (GO:0046479) | 3.42728221 |
52 | negative regulation of macrophage derived foam cell differentiation (GO:0010745) | 3.40100486 |
53 | reactive oxygen species biosynthetic process (GO:1903409) | 3.34886487 |
54 | positive regulation of myeloid leukocyte cytokine production involved in immune response (GO:0061081 | 3.34859043 |
55 | galactose catabolic process (GO:0019388) | 3.33676207 |
56 | regulation of mononuclear cell migration (GO:0071675) | 3.33504137 |
57 | microglial cell activation (GO:0001774) | 3.32380396 |
58 | response to stimulus involved in regulation of muscle adaptation (GO:0014874) | 3.32102747 |
59 | regulation of cardiac muscle contraction by calcium ion signaling (GO:0010882) | 3.29534677 |
60 | muscle cell cellular homeostasis (GO:0046716) | 3.26796655 |
61 | superoxide anion generation (GO:0042554) | 3.26521099 |
62 | positive regulation of syncytium formation by plasma membrane fusion (GO:0060143) | 3.26258775 |
63 | positive regulation of chemokine biosynthetic process (GO:0045080) | 3.24305739 |
64 | positive regulation of tumor necrosis factor biosynthetic process (GO:0042535) | 3.23316838 |
65 | immunoglobulin mediated immune response (GO:0016064) | 3.23058756 |
66 | pigmentation (GO:0043473) | 3.22314685 |
67 | macrophage activation (GO:0042116) | 3.20145791 |
68 | cellular response to reactive nitrogen species (GO:1902170) | 3.20086652 |
69 | regulation of calcineurin-NFAT signaling cascade (GO:0070884) | 3.18515004 |
70 | galactose metabolic process (GO:0006012) | 3.17780491 |
71 | oligosaccharide catabolic process (GO:0009313) | 3.15368204 |
72 | response to defenses of other organism involved in symbiotic interaction (GO:0052173) | 3.14414512 |
73 | response to host (GO:0075136) | 3.14414512 |
74 | response to host defenses (GO:0052200) | 3.14414512 |
75 | positive regulation of macrophage cytokine production (GO:0060907) | 3.13777319 |
76 | regulation of relaxation of muscle (GO:1901077) | 3.13373793 |
77 | positive regulation of interferon-beta production (GO:0032728) | 3.13291168 |
78 | calcium-mediated signaling using intracellular calcium source (GO:0035584) | 3.13054978 |
79 | Rap protein signal transduction (GO:0032486) | 3.12372750 |
80 | pigment biosynthetic process (GO:0046148) | 3.10656186 |
81 | negative regulation of interleukin-17 production (GO:0032700) | 3.10178760 |
82 | cardiac myofibril assembly (GO:0055003) | 3.07902341 |
83 | T-helper 1 type immune response (GO:0042088) | 3.07805185 |
84 | negative regulation of response to reactive oxygen species (GO:1901032) | 3.05230062 |
85 | regulation of ryanodine-sensitive calcium-release channel activity (GO:0060314) | 3.02911143 |
86 | regulation of syncytium formation by plasma membrane fusion (GO:0060142) | 3.01907065 |
87 | glycolipid catabolic process (GO:0019377) | 3.01578068 |
88 | response to muscle activity (GO:0014850) | 3.01519440 |
89 | positive regulation of cellular amide metabolic process (GO:0034250) | 3.00767959 |
90 | response to muramyl dipeptide (GO:0032495) | 2.99236641 |
91 | keratan sulfate catabolic process (GO:0042340) | 2.97908372 |
92 | natural killer cell mediated immunity (GO:0002228) | 2.97776677 |
93 | natural killer cell mediated cytotoxicity (GO:0042267) | 2.97776677 |
94 | myeloid cell activation involved in immune response (GO:0002275) | 2.97352021 |
95 | I-kappaB phosphorylation (GO:0007252) | 2.95758408 |
96 | * pigment cell differentiation (GO:0050931) | 2.94800300 |
97 | cellular response to zinc ion (GO:0071294) | 2.94406068 |
98 | negative regulation of protein localization to plasma membrane (GO:1903077) | 2.94025942 |
99 | heart contraction (GO:0060047) | 2.92806570 |
100 | heart process (GO:0003015) | 2.92806570 |
101 | actin filament-based movement (GO:0030048) | 2.92219873 |
102 | regulation of nitric-oxide synthase biosynthetic process (GO:0051769) | 2.90639687 |
103 | regulation of hydrogen peroxide-induced cell death (GO:1903205) | 2.90046504 |
104 | granulocyte activation (GO:0036230) | 2.86974720 |
105 | cellular response to epinephrine stimulus (GO:0071872) | 2.86725525 |
106 | low-density lipoprotein particle clearance (GO:0034383) | 2.82400221 |
107 | cardiac muscle contraction (GO:0060048) | 2.81546959 |
108 | actomyosin structure organization (GO:0031032) | 2.79808769 |
109 | positive regulation of membrane protein ectodomain proteolysis (GO:0051044) | 2.75678557 |
110 | striated muscle contraction (GO:0006941) | 2.74302714 |
111 | neutrophil activation (GO:0042119) | 2.73687655 |
112 | regulation of cholesterol storage (GO:0010885) | 2.73493700 |
113 | ceramide catabolic process (GO:0046514) | 2.73297196 |
114 | apoptotic cell clearance (GO:0043277) | 2.70395353 |
115 | cardiac muscle hypertrophy (GO:0003300) | 2.67923620 |
116 | positive regulation of chemokine production (GO:0032722) | 2.67583041 |
117 | regulation of superoxide metabolic process (GO:0090322) | 2.67526160 |
118 | platelet dense granule organization (GO:0060155) | 2.66889851 |
119 | * melanocyte differentiation (GO:0030318) | 2.66851935 |
120 | pigment metabolic process (GO:0042440) | 2.66531418 |
121 | fibroblast migration (GO:0010761) | 2.66258681 |
122 | response to interferon-alpha (GO:0035455) | 2.65794099 |
123 | positive regulation of mast cell activation involved in immune response (GO:0033008) | 2.64267342 |
124 | positive regulation of mast cell degranulation (GO:0043306) | 2.64267342 |
125 | positive regulation of calcium ion transmembrane transporter activity (GO:1901021) | 2.63417808 |
126 | intracellular pH reduction (GO:0051452) | 2.63415912 |
127 | negative regulation of ryanodine-sensitive calcium-release channel activity (GO:0060315) | 2.63094890 |
128 | cardiac muscle cell development (GO:0055013) | 2.60062457 |
129 | response to inactivity (GO:0014854) | 2.60045381 |
130 | positive regulation of mast cell activation (GO:0033005) | 2.59172916 |
131 | cell migration involved in heart development (GO:0060973) | 2.57593211 |
132 | regulation of actin filament-based movement (GO:1903115) | 2.57247031 |
133 | negative regulation of protein localization to cell surface (GO:2000009) | 2.57138279 |
134 | cellular response to type I interferon (GO:0071357) | 2.57059985 |
135 | type I interferon signaling pathway (GO:0060337) | 2.57059985 |
136 | positive regulation of heat generation (GO:0031652) | 2.56852312 |
137 | regulation of macrophage cytokine production (GO:0010935) | 2.56717017 |
138 | negative regulation of potassium ion transmembrane transporter activity (GO:1901017) | 2.56395958 |
139 | relaxation of cardiac muscle (GO:0055119) | 2.56391396 |
140 | positive regulation of toll-like receptor signaling pathway (GO:0034123) | 2.54859657 |
141 | response to type I interferon (GO:0034340) | 2.54800140 |
142 | regulation of receptor recycling (GO:0001919) | 2.53842068 |
143 | striated muscle hypertrophy (GO:0014897) | 2.53606374 |
144 | cellular response to interferon-alpha (GO:0035457) | 2.53453682 |
145 | pinocytosis (GO:0006907) | 2.51340900 |
146 | regulation of superoxide anion generation (GO:0032928) | 2.51111960 |
147 | negative regulation of lipid storage (GO:0010888) | 2.50929440 |
148 | phagocytosis, recognition (GO:0006910) | 2.50771168 |
149 | barbed-end actin filament capping (GO:0051016) | 2.50688329 |
150 | regulation of chemokine biosynthetic process (GO:0045073) | 2.50384628 |
151 | positive regulation of tumor necrosis factor superfamily cytokine production (GO:1903557) | 2.49957148 |
152 | eosinophil chemotaxis (GO:0048245) | 2.49567885 |
153 | semaphorin-plexin signaling pathway (GO:0071526) | 2.48840177 |
154 | detection of external biotic stimulus (GO:0098581) | 2.48573280 |
155 | regulation of interleukin-8 biosynthetic process (GO:0045414) | 2.47910887 |
156 | cellular response to arsenic-containing substance (GO:0071243) | 2.46931164 |
157 | hyaluronan catabolic process (GO:0030214) | 2.46560518 |
158 | regulation of macrophage derived foam cell differentiation (GO:0010743) | 2.46065190 |
159 | regulation of lipoprotein metabolic process (GO:0050746) | 2.43621042 |
160 | nerve growth factor signaling pathway (GO:0038180) | 2.43274231 |
161 | regulation of endothelial cell chemotaxis (GO:2001026) | 2.43089920 |
162 | positive regulation of interleukin-12 production (GO:0032735) | 2.42893511 |
163 | positive regulation of interleukin-6 production (GO:0032755) | 2.41544596 |
164 | phagosome maturation (GO:0090382) | 2.41127338 |
165 | endothelial cell morphogenesis (GO:0001886) | 2.40143695 |
166 | relaxation of muscle (GO:0090075) | 2.39876096 |
167 | basement membrane organization (GO:0071711) | 2.39771376 |
168 | cellular extravasation (GO:0045123) | 2.39254123 |
169 | * osteoclast differentiation (GO:0030316) | 2.37413826 |
170 | muscle hypertrophy (GO:0014896) | 2.37086706 |
171 | cardiac cell development (GO:0055006) | 2.35654712 |
172 | aromatic amino acid family metabolic process (GO:0009072) | 2.31769523 |
173 | tricarboxylic acid cycle (GO:0006099) | 2.29756294 |
174 | skeletal muscle adaptation (GO:0043501) | 2.27025540 |
175 | pH reduction (GO:0045851) | 2.26169804 |
176 | regulation of membrane protein ectodomain proteolysis (GO:0051043) | 2.24655876 |
177 | antigen processing and presentation via MHC class Ib (GO:0002475) | 2.23978066 |
178 | melanin biosynthetic process (GO:0042438) | 15.3191838 |
179 | melanin metabolic process (GO:0006582) | 13.8183207 |
180 | secondary metabolite biosynthetic process (GO:0044550) | 12.6199425 |
Rank | Gene Set | Z-score |
---|---|---|
1 | BP1_19119308_ChIP-ChIP_Hs578T_Human | 7.45625092 |
2 | IRF8_21731497_ChIP-ChIP_J774_Mouse | 6.00255236 |
3 | IRF8_22096565_ChIP-ChIP_GC-B_Human | 5.81464228 |
4 | * Nerf2_26677805_Chip-Seq_MACROPHAGESS_Mouse | 4.19301596 |
5 | IRF8_27001747_Chip-Seq_BMDM_Mouse | 4.12717465 |
6 | SMRT_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.92843235 |
7 | NCOR_22465074_ChIP-Seq_MACROPHAGES_Mouse | 3.47722269 |
8 | * IRF1_21803131_ChIP-Seq_MONOCYTES_Human | 3.19103978 |
9 | FOXP3_17237761_ChIP-ChIP_TREG_Mouse | 2.75956025 |
10 | IRF8_22096565_ChIP-ChIP_GC-B_Mouse | 2.75144404 |
11 | RELA_24523406_ChIP-Seq_FIBROSARCOMA_Human | 2.68943271 |
12 | * MYB_21317192_ChIP-Seq_ERMYB_Mouse | 2.54356264 |
13 | CDX2_19796622_ChIP-Seq_MESCs_Mouse | 2.47545487 |
14 | * NUCKS1_24931609_ChIP-Seq_HEPATOCYTES_Mouse | 2.45268621 |
15 | MECOM_23826213_ChIP-Seq_KASUMI_Mouse | 2.40043902 |
16 | PRDM16_22522345_ChIP-ChIP_PALATE_MESENCHYMAL_Mouse | 2.32284565 |
17 | STAT6_20620947_ChIP-Seq_CD4_POS_T_Human | 2.20639127 |
18 | EGR1_19374776_ChIP-ChIP_THP-1_Human | 2.12472327 |
19 | RUNX1_26923725_Chip-Seq_MACROPHAGESS_Mouse | 2.11766385 |
20 | VDR_24787735_ChIP-Seq_THP-1_Human | 2.02662064 |
21 | NR1H3_23393188_ChIP-Seq_ATHEROSCLEROTIC-FOAM_Human | 2.01001236 |
22 | GATA2_21666600_ChIP-Seq_HMVEC_Human | 1.98286976 |
23 | STAT3_20064451_ChIP-Seq_CD4+T_Mouse | 1.86795310 |
24 | BRD4_27068464_Chip-Seq_AML-cells_Mouse | 1.85804790 |
25 | STAT3_22323479_ChIP-Seq_MACROPHAGE_Mouse | 1.82297435 |
26 | PPARG_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.81942486 |
27 | * MITF_21258399_ChIP-Seq_MELANOMA_Human | 1.80629848 |
28 | PPARG_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.77604010 |
29 | PU_27001747_Chip-Seq_BMDM_Mouse | 1.77242521 |
30 | STAT4_19710469_ChIP-ChIP_TH1__Mouse | 1.72847372 |
31 | STAT5_23275557_ChIP-Seq_MAMMARY-EPITHELIUM_Mouse | 1.70304143 |
32 | CTNNB1_24651522_ChIP-Seq_LGR5+_INTESTINAL_STEM_Human | 1.66796592 |
33 | PPARD_23176727_ChIP-Seq_KERATINOCYTES_Mouse | 1.59937638 |
34 | CIITA_18437201_ChIP-ChIP_Raji_B_and_iDC_Human | 1.59584755 |
35 | NRF2_20460467_ChIP-Seq_MEFs_Mouse | 1.57864687 |
36 | NFE2L2_20460467_ChIP-Seq_MEFs_Mouse | 1.57864687 |
37 | SPI1_23127762_ChIP-Seq_K562_Human | 1.57545718 |
38 | SOX9_22984422_ChIP-ChIP_TESTIS_Rat | 1.56850293 |
39 | SPI1_22096565_ChIP-ChIP_GC-B_Mouse | 1.53561132 |
40 | AR_22383394_ChIP-Seq_PROSTATE_CANCER_Human | 1.52997229 |
41 | GATA4_21415370_ChIP-Seq_HL-1_Mouse | 1.51549651 |
42 | THRA_23701648_ChIP-Seq_CEREBELLUM_Mouse | 1.50670848 |
43 | CEBPB_21427703_ChIP-Seq_3T3-L1_Mouse | 1.50193246 |
44 | CEBPB_20176806_ChIP-Seq_MACROPHAGES_Mouse | 1.47807839 |
45 | TCF21_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.47404456 |
46 | EGR1_19032775_ChIP-ChIP_M12_Human | 1.47003158 |
47 | * SOX9_24532713_ChIP-Seq_HFSC_Mouse | 1.44998060 |
48 | CEBPD_21427703_ChIP-Seq_3T3-L1_Mouse | 1.39931140 |
49 | EZH2_27294783_Chip-Seq_NPCs_Mouse | 1.39733563 |
50 | LYL1_20887958_ChIP-Seq_HPC-7_Mouse | 1.38214467 |
51 | LXR_22158963_ChIP-Seq_LIVER_Mouse | 1.38012254 |
52 | * SMARCA4_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.37739721 |
53 | NFE2L2_22581777_ChIP-Seq_LYMPHOBLASTOID_Human | 1.36040954 |
54 | CJUN_26792858_Chip-Seq_BT549_Human | 1.35865128 |
55 | MEF2A_21415370_ChIP-Seq_HL-1_Mouse | 1.34805066 |
56 | VDR_23401126_ChIP-Seq_LCL-AND-THP1_Human | 1.34583358 |
57 | * ZNF217_24962896_ChIP-Seq_MCF-7_Human | 1.34134113 |
58 | EP300_21415370_ChIP-Seq_HL-1_Mouse | 1.32673967 |
59 | CEBPB_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 1.32391575 |
60 | BRD4_25478319_ChIP-Seq_HGPS_Human | 1.32138137 |
61 | TRIM28_21343339_ChIP-Seq_HEK293_Human | 1.31631960 |
62 | * SPI1_23547873_ChIP-Seq_NB4_Human | 1.31041189 |
63 | CHD7_19251738_ChIP-ChIP_MESCs_Mouse | 1.30872992 |
64 | PPARG_20176806_ChIP-Seq_3T3-L1_Mouse | 1.28775826 |
65 | PPARD_23208498_ChIP-Seq_MDA-MB-231_Human | 1.28738969 |
66 | CTNNB1_20460455_ChIP-Seq_HCT116_Human | 1.28087695 |
67 | TP53_16413492_ChIP-PET_HCT116_Human | 1.25481464 |
68 | ESR1_17901129_ChIP-ChIP_LIVER_Mouse | 1.22131877 |
69 | CEBPD_23245923_ChIP-Seq_MEFs_Mouse | 1.21213100 |
70 | NKX2-5_21415370_ChIP-Seq_HL-1_Mouse | 1.18156903 |
71 | RUNX_20019798_ChIP-Seq_JUKART_Human | 1.18009799 |
72 | * VDR_24763502_ChIP-Seq_THP-1_Human | 1.17972704 |
73 | TRP63_18441228_ChIP-ChIP_KERATINOCYTES_Mouse | 1.15121329 |
74 | CEBPB_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.14521884 |
75 | PPARG_19300518_ChIP-PET_3T3-L1_Mouse | 1.14331917 |
76 | PPAR_26484153_Chip-Seq_NCI-H1993_Human | 1.14003507 |
77 | CRX_20693478_ChIP-Seq_RETINA_Mouse | 1.13211564 |
78 | * TBX20_22080862_ChIP-Seq_HEART_Mouse | 1.13173321 |
79 | * TBX20_22328084_ChIP-Seq_HEART_Mouse | 1.13173321 |
80 | * POU3F2_20337985_ChIP-ChIP_501MEL_Human | 1.12538128 |
81 | SCL_19346495_ChIP-Seq_HPC-7_Human | 1.12443918 |
82 | SMAD4_19686287_ChIP-ChIP_HaCaT_Human | 1.11671193 |
83 | GATA1_19941826_ChIP-Seq_K562_Human | 1.11226752 |
84 | CLOCK_20551151_ChIP-Seq_293T_Human | 1.10945005 |
85 | SUZ12_27294783_Chip-Seq_NPCs_Mouse | 1.10762685 |
86 | TEAD4_22529382_ChIP-Seq_TROPHECTODERM_Mouse | 1.10716500 |
87 | * OLIG2_23332759_ChIP-Seq_OLIGODENDROCYTES_Mouse | 1.10549643 |
88 | SALL4_18804426_ChIP-ChIP_XEN_Mouse | 1.08406683 |
89 | TFEB_21752829_ChIP-Seq_HELA_Human | 1.08272422 |
90 | SMAD_19615063_ChIP-ChIP_OVARY_Human | 1.08069229 |
91 | GATA2_26923725_Chip-Seq_HEMANGIOBLAST_Mouse | 1.07981907 |
92 | * ESR1_22446102_ChIP-Seq_UTERUS_Mouse | 1.07310853 |
93 | FOXA1_26769127_Chip-Seq_PDAC-Cell_line_Human | 1.07021587 |
94 | SOX2_20726797_ChIP-Seq_SW620_Human | 1.06578858 |
95 | TCFCP2L1_18555785_Chip-Seq_ESCs_Mouse | 1.06426114 |
96 | GATA3_26560356_Chip-Seq_TH2_Human | 1.05935873 |
97 | CDX2_21402776_ChIP-Seq_INTESTINAL-VILLUS_Mouse | 1.04745359 |
98 | * SCL_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 1.03983749 |
99 | ESR1_21235772_ChIP-Seq_MCF-7_Human | 1.03912612 |
100 | NOTCH1_17114293_ChIP-ChIP_T-ALL_Human | 1.03704305 |
101 | CEBPA_20513432_ChIP-Seq_MACROPHAGES_Mouse | 1.02972079 |
102 | NR1I2_20693526_ChIP-Seq_LIVER_Mouse | 1.02961029 |
103 | E2F1_18555785_Chip-Seq_ESCs_Mouse | 1.02877526 |
104 | * FOXM1_26456572_ChIP-Seq_MCF-7_Human | 1.01788564 |
105 | JUND_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 1.01259718 |
106 | FOXO3_23340844_ChIP-Seq_DLD1_Human | 1.01233632 |
107 | PIAS1_25552417_ChIP-Seq_VCAP_Human | 0.99966505 |
108 | HIF1A_21447827_ChIP-Seq_MCF-7_Human | 0.99831813 |
109 | * GATA1_19941827_ChIP-Seq_MEL86_Mouse | 0.98945009 |
110 | * PU.1_20176806_ChIP-Seq_MACROPHAGES_Mouse | 0.98873472 |
111 | NFIB_24661679_ChIP-Seq_LUNG_Mouse | 0.98858492 |
112 | RUNX1_22412390_ChIP-Seq_EML_Mouse | 0.98850070 |
113 | JUN_26020271_ChIP-Seq_SMOOTH_MUSCLE_Human | 0.98166883 |
114 | * SMAD2_18955504_ChIP-ChIP_HaCaT_Human | 0.97119275 |
115 | * SMAD3_18955504_ChIP-ChIP_HaCaT_Human | 0.97119275 |
116 | OCT4_21477851_ChIP-Seq_ESCs_Mouse | 0.96071006 |
117 | * BACH1_22875853_ChIP-PCR_HELA_AND_SCP4_Human | 0.95722823 |
118 | PRDM5_23873026_ChIP-Seq_MEFs_Mouse | 0.95242143 |
119 | * SMAD4_21799915_ChIP-Seq_A2780_Human | 0.95237395 |
120 | RARG_19884340_ChIP-ChIP_MEFs_Mouse | 0.94917503 |
121 | TCF7L2_21901280_ChIP-Seq_H4IIE_Rat | 0.93543466 |
122 | NFE2_27457419_Chip-Seq_LIVER_Mouse | 0.93292734 |
123 | MEIS1_20887958_ChIP-Seq_HPC-7_Mouse | 0.93007547 |
124 | SPI1_20176806_ChIP-Seq_THIOMACROPHAGE_Mouse | 0.91125022 |
125 | GATA3_27048872_Chip-Seq_THYMUS_Human | 0.88666676 |
126 | SMARCA4_20176728_ChIP-ChIP_TSCs_Mouse | 0.87998070 |
127 | GATA1_22025678_ChIP-Seq_K562_Human | 0.87506776 |
128 | RUNX2_24764292_ChIP-Seq_MC3T3_Mouse | 0.86848181 |
129 | PU.1_20513432_ChIP-Seq_MACROPHAGES_Mouse | 0.85243393 |
130 | MYB_26560356_Chip-Seq_TH2_Human | 0.84021261 |
131 | * LMO2_20887958_ChIP-Seq_HPC-7_Mouse | 0.81495092 |
132 | WT1_19549856_ChIP-ChIP_CCG9911_Human | 0.81092529 |
133 | TAF7L_23326641_ChIP-Seq_C3H10T1-2_Mouse | 0.80494418 |
134 | ATF3_23680149_ChIP-Seq_GBM1-GSC_Human | 0.78889810 |
135 | TP63_23658742_ChIP-Seq_EP156T_Human | 0.78631097 |
136 | FOXO1_25302145_ChIP-Seq_T-LYMPHOCYTE_Mouse | 0.77589308 |
137 | P63_26484246_Chip-Seq_KERATINOCYTES_Human | 0.76581030 |
138 | FOXO1_23066095_ChIP-Seq_LIVER_Mouse | 0.76523551 |
139 | * GATA2_19941826_ChIP-Seq_K562_Human | 0.76284765 |
140 | RUNX1_20887958_ChIP-Seq_HPC-7_Mouse | 0.76142443 |
141 | * GATA1_21571218_ChIP-Seq_MEGAKARYOCYTES_Human | 0.75002115 |
142 | ESR1_20079471_ChIP-ChIP_T-47D_Human | 0.73994408 |
Rank | Gene Set | Z-score |
---|---|---|
1 | * MP0000372_irregular_coat_pigmentation | 7.97348937 |
2 | * MP0005171_absent_coat_pigmentation | 5.69974218 |
3 | MP0005257_abnormal_intraocular_pressure | 3.89860381 |
4 | * MP0005408_hypopigmentation | 3.62541604 |
5 | * MP0000371_diluted_coat_color | 3.53585423 |
6 | MP0005058_abnormal_lysosome_morphology | 2.91652293 |
7 | MP0000569_abnormal_digit_pigmentation | 2.83306087 |
8 | MP0001835_abnormal_antigen_presentation | 2.33452252 |
9 | * MP0005174_abnormal_tail_pigmentation | 2.31502263 |
10 | MP0004510_myositis | 2.24398135 |
11 | MP0006082_CNS_inflammation | 2.23582937 |
12 | MP0009785_altered_susceptibility_to | 2.07917998 |
13 | MP0002148_abnormal_hypersensitivity_rea | 2.07229928 |
14 | MP0003436_decreased_susceptibility_to | 2.04124478 |
15 | MP0003878_abnormal_ear_physiology | 2.02646845 |
16 | MP0005377_hearing/vestibular/ear_phenot | 2.02646845 |
17 | * MP0002095_abnormal_skin_pigmentation | 1.97496566 |
18 | * MP0002419_abnormal_innate_immunity | 1.94759646 |
19 | * MP0001324_abnormal_eye_pigmentation | 1.93482423 |
20 | MP0005409_darkened_coat_color | 1.92203263 |
21 | MP0004084_abnormal_cardiac_muscle | 1.85984563 |
22 | * MP0002075_abnormal_coat/hair_pigmentati | 1.83847664 |
23 | * MP0002877_abnormal_melanocyte_morpholog | 1.83396980 |
24 | MP0003172_abnormal_lysosome_physiology | 1.82070153 |
25 | MP0005075_abnormal_melanosome_morpholog | 1.80104017 |
26 | MP0003303_peritoneal_inflammation | 1.79888507 |
27 | MP0003191_abnormal_cellular_cholesterol | 1.70882052 |
28 | MP0005000_abnormal_immune_tolerance | 1.69923063 |
29 | MP0003950_abnormal_plasma_membrane | 1.65036080 |
30 | MP0003828_pulmonary_edema | 1.61358025 |
31 | MP0005025_abnormal_response_to | 1.60937895 |
32 | MP0003705_abnormal_hypodermis_morpholog | 1.60132526 |
33 | MP0003724_increased_susceptibility_to | 1.59769005 |
34 | * MP0004381_abnormal_hair_follicle | 1.59683055 |
35 | MP0000751_myopathy | 1.59248085 |
36 | MP0008438_abnormal_cutaneous_collagen | 1.59165998 |
37 | MP0003646_muscle_fatigue | 1.58801800 |
38 | MP0000343_altered_response_to | 1.54914558 |
39 | MP0003806_abnormal_nucleotide_metabolis | 1.52480292 |
40 | MP0004233_abnormal_muscle_weight | 1.46329437 |
41 | * MP0001186_pigmentation_phenotype | 1.44430410 |
42 | * MP0000015_abnormal_ear_pigmentation | 1.43445840 |
43 | MP0003566_abnormal_cell_adhesion | 1.37682291 |
44 | MP0009840_abnormal_foam_cell | 1.37569256 |
45 | MP0005387_immune_system_phenotype | 1.33003287 |
46 | MP0001790_abnormal_immune_system | 1.33003287 |
47 | MP0005670_abnormal_white_adipose | 1.32749787 |
48 | MP0003690_abnormal_glial_cell | 1.29268718 |
49 | MP0003448_altered_tumor_morphology | 1.29052293 |
50 | * MP0002452_abnormal_antigen_presenting | 1.28697565 |
51 | MP0002102_abnormal_ear_morphology | 1.28459795 |
52 | MP0002090_abnormal_vision | 1.26316678 |
53 | MP0000747_muscle_weakness | 1.24197762 |
54 | * MP0003136_yellow_coat_color | 1.23185968 |
55 | MP0001533_abnormal_skeleton_physiology | 1.20544757 |
56 | MP0008775_abnormal_heart_ventricle | 1.20266874 |
57 | MP0002269_muscular_atrophy | 1.17418167 |
58 | MP0004036_abnormal_muscle_relaxation | 1.14761528 |
59 | MP0002723_abnormal_immune_serum | 1.14316265 |
60 | MP0005164_abnormal_response_to | 1.13768047 |
61 | MP0003453_abnormal_keratinocyte_physiol | 1.12477207 |
62 | MP0005464_abnormal_platelet_physiology | 1.11296275 |
63 | MP0000685_abnormal_immune_system | 1.08810998 |
64 | MP0005620_abnormal_muscle_contractility | 1.08762057 |
65 | MP0002972_abnormal_cardiac_muscle | 1.08599777 |
66 | * MP0005197_abnormal_uvea_morphology | 1.06543715 |
67 | MP0004947_skin_inflammation | 1.05558307 |
68 | MP0003075_altered_response_to | 1.01256401 |
69 | MP0000920_abnormal_myelination | 1.00697392 |
70 | MP0001800_abnormal_humoral_immune | 1.00574311 |
71 | MP0005671_abnormal_response_to | 0.98551190 |
72 | * MP0001819_abnormal_immune_cell | 0.97770303 |
73 | MP0004130_abnormal_muscle_cell | 0.96031363 |
74 | * MP0002420_abnormal_adaptive_immunity | 0.95257932 |
75 | MP0010307_abnormal_tumor_latency | 0.94734208 |
76 | * MP0002998_abnormal_bone_remodeling | 0.94643528 |
77 | MP0005165_increased_susceptibility_to | 0.92372935 |
78 | MP0009764_decreased_sensitivity_to | 0.92371359 |
79 | MP0000733_abnormal_muscle_development | 0.92050799 |
80 | MP0000604_amyloidosis | 0.91416860 |
81 | MP0001845_abnormal_inflammatory_respons | 0.90168709 |
82 | MP0004272_abnormal_basement_membrane | 0.89655952 |
83 | MP0005451_abnormal_body_composition | 0.89510383 |
84 | MP0002332_abnormal_exercise_endurance | 0.89169137 |
85 | MP0001544_abnormal_cardiovascular_syste | 0.89013493 |
86 | MP0005385_cardiovascular_system_phenoty | 0.89013493 |
87 | MP0000749_muscle_degeneration | 0.88132587 |
88 | MP0008260_abnormal_autophagy | 0.86997789 |
89 | MP0002837_dystrophic_cardiac_calcinosis | 0.86936575 |
90 | MP0005167_abnormal_blood-brain_barrier | 0.86079343 |
91 | MP0000759_abnormal_skeletal_muscle | 0.85844988 |
92 | MP0004087_abnormal_muscle_fiber | 0.85415263 |
93 | MP0003091_abnormal_cell_migration | 0.85090233 |
94 | MP0006138_congestive_heart_failure | 0.84834871 |
95 | MP0008004_abnormal_stomach_pH | 0.84684182 |
96 | MP0005330_cardiomyopathy | 0.84543029 |
97 | MP0008469_abnormal_protein_level | 0.83212545 |
98 | MP0009278_abnormal_bone_marrow | 0.83002896 |
99 | MP0001853_heart_inflammation | 0.82393595 |
100 | MP0004215_abnormal_myocardial_fiber | 0.81779602 |
101 | MP0002405_respiratory_system_inflammati | 0.81052681 |
102 | MP0010630_abnormal_cardiac_muscle | 0.80879827 |
103 | MP0004145_abnormal_muscle_electrophysio | 0.77976853 |
104 | MP0005166_decreased_susceptibility_to | 0.77753069 |
105 | MP0006054_spinal_hemorrhage | 0.77131643 |
106 | MP0005023_abnormal_wound_healing | 0.75587198 |
107 | MP0004885_abnormal_endolymph | 0.73846398 |
108 | MP0001958_emphysema | 0.72685971 |
109 | MP0004484_altered_response_of | 0.71800926 |
110 | * MP0002938_white_spotting | 0.71526024 |
111 | MP0003567_abnormal_fetal_cardiomyocyte | 0.70140997 |
112 | MP0003186_abnormal_redox_activity | 0.68865660 |
113 | MP0005369_muscle_phenotype | 0.67068888 |
114 | MP0000858_altered_metastatic_potential | 0.66520012 |
115 | MP0003221_abnormal_cardiomyocyte_apopto | 0.65893963 |
116 | MP0002106_abnormal_muscle_physiology | 0.65729611 |
117 | MP0006036_abnormal_mitochondrial_physio | 0.64845429 |
118 | MP0002006_tumorigenesis | 0.63637657 |
119 | MP0000767_abnormal_smooth_muscle | 0.63169378 |
120 | MP0001851_eye_inflammation | 0.56968912 |
121 | MP0003279_aneurysm | 0.56822654 |
122 | MP0003011_delayed_dark_adaptation | 0.56028758 |
123 | MP0005275_abnormal_skin_tensile | 0.55433038 |
124 | MP0003656_abnormal_erythrocyte_physiolo | 0.55154577 |
125 | * MP0005193_abnormal_anterior_eye | 0.53286761 |
126 | MP0000750_abnormal_muscle_regeneration | 0.53023716 |
127 | * MP0005253_abnormal_eye_physiology | 0.52165876 |
128 | MP0003300_gastrointestinal_ulcer | 0.49948489 |
129 | MP0003137_abnormal_impulse_conducting | 0.49607142 |
130 | MP0010234_abnormal_vibrissa_follicle | 0.49185706 |
131 | MP0001661_extended_life_span | 0.45602968 |
132 | MP0003634_abnormal_glial_cell | 0.41945334 |
133 | MP0000465_gastrointestinal_hemorrhage | 0.41712710 |
134 | MP0000358_abnormal_cell_content/ | 0.41629654 |
135 | MP0002971_abnormal_brown_adipose | 0.39891705 |
136 | MP0002896_abnormal_bone_mineralization | 0.38304467 |
137 | * MP0000367_abnormal_coat/_hair | 0.37136191 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Ocular albinism (HP:0001107) | 6.14082182 |
2 | * Aplasia/Hypoplasia of the macula (HP:0008059) | 6.07117314 |
3 | Recurrent abscess formation (HP:0002722) | 5.74692709 |
4 | * Patchy hypopigmentation of hair (HP:0011365) | 5.67620901 |
5 | * Aplasia/Hypoplasia affecting the retina (HP:0008061) | 5.61664982 |
6 | Eczematoid dermatitis (HP:0000976) | 5.37850400 |
7 | * Blue irides (HP:0000635) | 5.37628587 |
8 | Recurrent bacterial skin infections (HP:0005406) | 5.23746252 |
9 | Iris hypopigmentation (HP:0007730) | 5.14294057 |
10 | Recurrent gram-negative bacterial infections (HP:0005420) | 4.67743585 |
11 | Subacute progressive viral hepatitis (HP:0006572) | 4.59404649 |
12 | * Hypoplasia of the fovea (HP:0007750) | 4.50880269 |
13 | * Aplasia/Hypoplasia of the fovea (HP:0008060) | 4.50880269 |
14 | Abnormal auditory evoked potentials (HP:0006958) | 4.35781081 |
15 | Hypopigmentation of the fundus (HP:0007894) | 4.30316034 |
16 | Abnormality of macrophages (HP:0004311) | 4.29212842 |
17 | Systemic lupus erythematosus (HP:0002725) | 4.13097481 |
18 | Nemaline bodies (HP:0003798) | 4.08332619 |
19 | Muscle fiber inclusion bodies (HP:0100299) | 3.98247852 |
20 | Muscle fiber cytoplasmatic inclusion bodies (HP:0100303) | 3.95438172 |
21 | Asymmetric septal hypertrophy (HP:0001670) | 3.84041995 |
22 | * Abnormality of the fovea (HP:0000493) | 3.70557657 |
23 | Increased cerebral lipofuscin (HP:0011813) | 3.59373368 |
24 | Exercise-induced muscle cramps (HP:0003710) | 3.56020153 |
25 | Orchitis (HP:0100796) | 3.51840731 |
26 | * Generalized hypopigmentation (HP:0007513) | 3.42737268 |
27 | Frequent falls (HP:0002359) | 3.39298659 |
28 | Vacuolated lymphocytes (HP:0001922) | 3.39284621 |
29 | Retrobulbar optic neuritis (HP:0100654) | 3.36291178 |
30 | Optic neuritis (HP:0100653) | 3.36291178 |
31 | Mediastinal lymphadenopathy (HP:0100721) | 3.31626369 |
32 | Axonal loss (HP:0003447) | 3.27964230 |
33 | Increased neuronal autofluorescent lipopigment (HP:0002074) | 3.26145740 |
34 | Dysostosis multiplex (HP:0000943) | 3.24068037 |
35 | Type 1 muscle fiber predominance (HP:0003803) | 3.16846580 |
36 | Myositis (HP:0100614) | 3.12880571 |
37 | Gingivitis (HP:0000230) | 3.09660298 |
38 | Mucopolysacchariduria (HP:0008155) | 3.00865692 |
39 | Urinary glycosaminoglycan excretion (HP:0003541) | 3.00865692 |
40 | * Albinism (HP:0001022) | 3.00181254 |
41 | Exercise-induced myalgia (HP:0003738) | 2.96995172 |
42 | Abnormality of liposaccharide metabolism (HP:0010968) | 2.92996591 |
43 | Abnormality of glycosphingolipid metabolism (HP:0004343) | 2.92996591 |
44 | Abnormality of glycolipid metabolism (HP:0010969) | 2.92996591 |
45 | Distal lower limb muscle weakness (HP:0009053) | 2.84094120 |
46 | Recurrent skin infections (HP:0001581) | 2.82779419 |
47 | Micronodular cirrhosis (HP:0001413) | 2.82028670 |
48 | Abnormality of polysaccharide metabolism (HP:0011012) | 2.80674139 |
49 | Abnormality of glycosaminoglycan metabolism (HP:0004371) | 2.80674139 |
50 | Abnormality of mucopolysaccharide metabolism (HP:0011020) | 2.80674139 |
51 | Bundle branch block (HP:0011710) | 2.76655221 |
52 | Viral hepatitis (HP:0006562) | 2.72765398 |
53 | Abnormality of the calf musculature (HP:0001430) | 2.64022701 |
54 | Thick nail (HP:0001805) | 2.62110752 |
55 | Stomatitis (HP:0010280) | 2.61563319 |
56 | Elevated erythrocyte sedimentation rate (HP:0003565) | 2.55762915 |
57 | Muscle fiber splitting (HP:0003555) | 2.54151653 |
58 | Myoglobinuria (HP:0002913) | 2.53679067 |
59 | Primitive reflexes (palmomental, snout, glabellar) (HP:0002476) | 2.52459589 |
60 | Vertebral compression fractures (HP:0002953) | 2.51096448 |
61 | Rhabdomyolysis (HP:0003201) | 2.50533682 |
62 | Increased connective tissue (HP:0009025) | 2.49256141 |
63 | Freckling (HP:0001480) | 2.43790374 |
64 | Sudden death (HP:0001699) | 2.42662728 |
65 | Cholecystitis (HP:0001082) | 2.42582297 |
66 | Abnormal gallbladder physiology (HP:0012438) | 2.42582297 |
67 | Obstructive lung disease (HP:0006536) | 2.42196126 |
68 | Chronic obstructive pulmonary disease (HP:0006510) | 2.42196126 |
69 | Loss of speech (HP:0002371) | 2.41166738 |
70 | Hematochezia (HP:0002573) | 2.40158576 |
71 | Generalized hypopigmentation of hair (HP:0011358) | 2.37597685 |
72 | Osteolytic defects of the hand bones (HP:0009699) | 2.36406387 |
73 | Osteolytic defects of the phalanges of the hand (HP:0009771) | 2.36406387 |
74 | * Premature graying of hair (HP:0002216) | 2.31693975 |
75 | Arterial thrombosis (HP:0004420) | 2.27952657 |
76 | Centrally nucleated skeletal muscle fibers (HP:0003687) | 2.25769989 |
77 | Conjunctival telangiectasia (HP:0000524) | 2.24695206 |
78 | Autoimmune thrombocytopenia (HP:0001973) | 2.24483951 |
79 | Intracellular accumulation of autofluorescent lipopigment storage material (HP:0003204) | 2.23906652 |
80 | Spontaneous hematomas (HP:0007420) | 2.22722300 |
81 | Ventricular tachycardia (HP:0004756) | 2.17862149 |
82 | Pulmonary infiltrates (HP:0002113) | 2.17558868 |
83 | * Heterochromia iridis (HP:0001100) | 2.16897311 |
84 | Dilated cardiomyopathy (HP:0001644) | 2.16520654 |
85 | Petechiae (HP:0000967) | 2.15908261 |
86 | Prostate neoplasm (HP:0100787) | 2.14598781 |
87 | Lipoatrophy (HP:0100578) | 2.13861900 |
88 | Tetraparesis (HP:0002273) | 2.13680663 |
89 | Urticaria (HP:0001025) | 2.13530992 |
90 | Keratoconjunctivitis sicca (HP:0001097) | 2.13121655 |
91 | Disinhibition (HP:0000734) | 2.12654542 |
92 | Myocardial infarction (HP:0001658) | 2.12587572 |
93 | Neck muscle weakness (HP:0000467) | 2.11866317 |
94 | Vasculitis (HP:0002633) | 2.11116124 |
95 | Recurrent fungal infections (HP:0002841) | 2.09237814 |
96 | Muscle hypertrophy of the lower extremities (HP:0008968) | 2.09170445 |
97 | Pustule (HP:0200039) | 2.09009131 |
98 | Skin nodule (HP:0200036) | 2.08595148 |
99 | Basal ganglia calcification (HP:0002135) | 2.06140230 |
100 | Abnormality of the left ventricular outflow tract (HP:0011103) | 2.05930554 |
101 | Subaortic stenosis (HP:0001682) | 2.05930554 |
102 | Increased IgM level (HP:0003496) | 2.02362274 |
103 | Cerebral inclusion bodies (HP:0100314) | 2.01761770 |
104 | Scapular winging (HP:0003691) | 2.00190388 |
105 | Hepatosplenomegaly (HP:0001433) | 1.99053359 |
106 | Increased mean platelet volume (HP:0011877) | 1.98129652 |
107 | Hyporeflexia of lower limbs (HP:0002600) | 1.97376634 |
108 | Abnormality of vision evoked potentials (HP:0000649) | 1.96838041 |
109 | Glomerulonephritis (HP:0000099) | 1.96787640 |
110 | Hepatocellular carcinoma (HP:0001402) | 1.96384762 |
111 | Osteomyelitis (HP:0002754) | 1.96346209 |
112 | Esophageal neoplasm (HP:0100751) | 1.94932737 |
113 | Neoplasm of head and neck (HP:0012288) | 1.94932737 |
114 | Periodontitis (HP:0000704) | 1.93892403 |
115 | Cellulitis (HP:0100658) | 1.92492319 |
116 | Atrial fibrillation (HP:0005110) | 1.90138070 |
117 | Keratoconjunctivitis (HP:0001096) | 1.89411777 |
118 | Mucosal telangiectasiae (HP:0100579) | 1.88980345 |
119 | Calf muscle hypertrophy (HP:0008981) | 1.88698816 |
120 | Upper limb muscle weakness (HP:0003484) | 1.88434166 |
121 | Purpura (HP:0000979) | 1.88267764 |
122 | Abnormality of glycolysis (HP:0004366) | 1.87285880 |
123 | * White forelock (HP:0002211) | 1.86773072 |
124 | Abnormality of skeletal muscle fiber size (HP:0012084) | 1.86685417 |
125 | Spastic paraparesis (HP:0002313) | 1.86591800 |
126 | Cerebral aneurysm (HP:0004944) | 1.84995102 |
127 | * Hypoplasia of the iris (HP:0007676) | 1.84931614 |
128 | EMG: myopathic abnormalities (HP:0003458) | 1.82629849 |
129 | Distal lower limb amyotrophy (HP:0008944) | 1.80766658 |
130 | Peripheral demyelination (HP:0011096) | 1.80456224 |
131 | Epidermoid cyst (HP:0200040) | 1.79076529 |
132 | Conjunctival hamartoma (HP:0100780) | 1.79012032 |
133 | Pulmonary artery stenosis (HP:0004415) | 1.78498008 |
134 | Neurofibrillary tangles (HP:0002185) | 1.78208149 |
135 | Prolonged neonatal jaundice (HP:0006579) | 1.77375553 |
136 | Gingival bleeding (HP:0000225) | 1.75727124 |
137 | Bone pain (HP:0002653) | 1.75300484 |
138 | Nausea (HP:0002018) | 1.74811864 |
139 | Coarse hair (HP:0002208) | 1.74406890 |
140 | Abnormality of the vasculature of the conjunctiva (HP:0008054) | 1.73043728 |
141 | Increased variability in muscle fiber diameter (HP:0003557) | 1.73024941 |
142 | J-shaped sella turcica (HP:0002680) | 1.72264566 |
143 | Bulbar palsy (HP:0001283) | 1.68346066 |
144 | Decreased motor nerve conduction velocity (HP:0003431) | 1.68321383 |
145 | Abnormal atrioventricular conduction (HP:0005150) | 1.68179667 |
146 | Abnormal platelet volume (HP:0011876) | 1.65661249 |
147 | Distal arthrogryposis (HP:0005684) | 1.64997183 |
148 | Aortic aneurysm (HP:0004942) | 1.64319712 |
149 | Horizontal nystagmus (HP:0000666) | 1.62397814 |
150 | Paraparesis (HP:0002385) | 1.60478144 |
151 | Hypoalphalipoproteinemia (HP:0003233) | 1.59924887 |
152 | Tongue fasciculations (HP:0001308) | 1.58773271 |
153 | Primary atrial arrhythmia (HP:0001692) | 1.58748969 |
154 | Protrusio acetabuli (HP:0003179) | 1.58269438 |
Rank | Gene Set | Z-score |
---|---|---|
1 | MST1R | 8.98199761 |
2 | MET | 4.09680026 |
3 | BMX | 3.55181809 |
4 | PBK | 3.31481786 |
5 | RIPK4 | 2.86100771 |
6 | FER | 2.81318067 |
7 | MAP3K14 | 2.79747618 |
8 | BLK | 2.77491131 |
9 | PKN2 | 2.73149986 |
10 | TBK1 | 2.54115632 |
11 | MAP3K3 | 2.32199727 |
12 | TTN | 2.13570475 |
13 | ACVR1B | 1.98480317 |
14 | MAPKAPK3 | 1.85384969 |
15 | TYK2 | 1.84853452 |
16 | IRAK4 | 1.78043928 |
17 | EPHB1 | 1.68318554 |
18 | NEK1 | 1.65059842 |
19 | OBSCN | 1.64367511 |
20 | PIK3CG | 1.63804410 |
21 | IRAK3 | 1.63633753 |
22 | EPHA3 | 1.61658310 |
23 | NEK9 | 1.56903939 |
24 | PHKG2 | 1.52780135 |
25 | PHKG1 | 1.52780135 |
26 | TRIB3 | 1.52034959 |
27 | MAP3K13 | 1.49620316 |
28 | MAPK12 | 1.45066930 |
29 | LMTK2 | 1.42291850 |
30 | IKBKB | 1.39058419 |
31 | IKBKE | 1.38374792 |
32 | TRPM7 | 1.37288208 |
33 | JAK1 | 1.28957907 |
34 | STK4 | 1.24007948 |
35 | EIF2AK1 | 1.23199135 |
36 | TGFBR2 | 1.22130796 |
37 | PAK3 | 1.21072527 |
38 | CCNB1 | 1.18099403 |
39 | KIT | 1.14451906 |
40 | DMPK | 1.10112475 |
41 | MUSK | 1.05540226 |
42 | JAK3 | 1.05344236 |
43 | MAP2K1 | 1.02849934 |
44 | FGR | 1.02705270 |
45 | LIMK1 | 1.00129100 |
46 | BMPR2 | 0.99895096 |
47 | PTK2B | 0.97281316 |
48 | CSK | 0.94140889 |
49 | FGFR1 | 0.93702894 |
50 | GRK7 | 0.87089131 |
51 | MAP4K1 | 0.83685609 |
52 | MAPK7 | 0.83178616 |
53 | PAK4 | 0.81778585 |
54 | PTK2 | 0.81613004 |
55 | MYLK | 0.81112961 |
56 | ERBB4 | 0.81097018 |
57 | FRK | 0.79940711 |
58 | ERN1 | 0.79747848 |
59 | AKT2 | 0.76271129 |
60 | LATS2 | 0.76014448 |
61 | ABL2 | 0.75742363 |
62 | DDR2 | 0.75560691 |
63 | NEK6 | 0.75376237 |
64 | TRIM28 | 0.73810994 |
65 | SCYL2 | 0.73027217 |
66 | JAK2 | 0.71151389 |
67 | CDC42BPA | 0.68931681 |
68 | HCK | 0.68543523 |
69 | LYN | 0.67802367 |
70 | TXK | 0.65444816 |
71 | PAK1 | 0.65383023 |
72 | FLT3 | 0.64027388 |
73 | ZAK | 0.62885518 |
74 | MAP3K2 | 0.62344034 |
75 | ABL1 | 0.62220107 |
76 | CDK6 | 0.61638649 |
77 | CHUK | 0.61527513 |
78 | STK3 | 0.60533671 |
79 | PTK6 | 0.59084162 |
80 | WEE1 | 0.58295241 |
81 | CAMK2D | 0.57651818 |
82 | FGFR3 | 0.56680465 |
83 | ARAF | 0.56565994 |
84 | CSF1R | 0.56180868 |
85 | ZAP70 | 0.55940075 |
86 | ICK | 0.55889121 |
87 | MAPKAPK5 | 0.54901840 |
88 | PRKCD | 0.54416956 |
89 | LCK | 0.53784997 |
90 | PRKCQ | 0.53424871 |
91 | PDGFRB | 0.52895748 |
92 | STK24 | 0.52276174 |
93 | EGFR | 0.52227533 |
94 | PIK3CA | 0.52099561 |
95 | PAK6 | 0.50385050 |
96 | RIPK1 | 0.49328213 |
97 | KSR2 | 0.49220608 |
98 | CAMK1D | 0.49107423 |
99 | CSNK1A1L | 0.48982013 |
100 | PRKCH | 0.48925150 |
101 | PIM2 | 0.48600723 |
102 | TGFBR1 | 0.48152247 |
103 | EIF2AK3 | 0.48144637 |
104 | MAP3K5 | 0.48022931 |
105 | SIK3 | 0.47946712 |
106 | LRRK2 | 0.47931228 |
107 | MATK | 0.47856160 |
108 | PRKCE | 0.47726047 |
109 | ADRBK1 | 0.46011258 |
110 | PAK2 | 0.45866366 |
111 | CSNK1G2 | 0.45790283 |
112 | PDPK1 | 0.42847853 |
113 | PKN1 | 0.42786015 |
114 | CAMK2A | 0.41505329 |
115 | NME2 | 0.41199556 |
116 | BMPR1B | 0.41064152 |
117 | MAP3K6 | 0.40754667 |
118 | MOS | 0.39866167 |
119 | STK39 | 0.39102092 |
120 | ILK | 0.39006418 |
121 | CSNK1G3 | 0.39005698 |
122 | ERBB3 | 0.38524413 |
123 | PIM1 | 0.38392567 |
124 | MAP2K3 | 0.37555967 |
125 | YES1 | 0.37525809 |
126 | STK10 | 0.37296149 |
127 | PDK1 | 0.37132552 |
128 | MST4 | 0.36623140 |
129 | MAP3K11 | 0.36515744 |
130 | MELK | 0.35949884 |
131 | MAPK4 | 0.35617639 |
132 | PRKD1 | 0.34771658 |
133 | * GSK3A | 0.34527336 |
134 | PRKG2 | 0.34418500 |
135 | WNK1 | 0.33942394 |
136 | MAP3K10 | 0.33672799 |
137 | INSR | 0.33434442 |
138 | PLK2 | 0.33274213 |
139 | LATS1 | 0.32140080 |
140 | ROCK1 | 0.31711521 |
141 | SYK | 0.30380393 |
142 | IGF1R | 0.29290944 |
143 | CAMK2G | 0.29222718 |
144 | NUAK1 | 0.28998849 |
145 | SGK3 | 0.28836349 |
146 | CLK1 | 0.27925591 |
147 | IRAK1 | 0.27890816 |
148 | CSNK1G1 | 0.27719542 |
149 | PDGFRA | 0.27208093 |
150 | PDK2 | 0.26774077 |
151 | MAPKAPK2 | 0.26742747 |
152 | FYN | 0.25998218 |
153 | PRPF4B | 0.25659761 |
154 | EIF2AK2 | 0.25308585 |
155 | PRKAA2 | 0.24873040 |
Rank | Gene Set | Z-score |
---|---|---|
1 | Staphylococcus aureus infection_Homo sapiens_hsa05150 | 3.00364858 |
2 | Leishmaniasis_Homo sapiens_hsa05140 | 2.87122303 |
3 | Malaria_Homo sapiens_hsa05144 | 2.79685824 |
4 | Glycosaminoglycan degradation_Homo sapiens_hsa00531 | 2.78126950 |
5 | Toll-like receptor signaling pathway_Homo sapiens_hsa04620 | 2.70076571 |
6 | Tyrosine metabolism_Homo sapiens_hsa00350 | 2.49341309 |
7 | Lysosome_Homo sapiens_hsa04142 | 2.46732885 |
8 | Legionellosis_Homo sapiens_hsa05134 | 2.27913109 |
9 | Rheumatoid arthritis_Homo sapiens_hsa05323 | 2.26756055 |
10 | Graft-versus-host disease_Homo sapiens_hsa05332 | 2.25767437 |
11 | Pentose phosphate pathway_Homo sapiens_hsa00030 | 2.21652702 |
12 | Tuberculosis_Homo sapiens_hsa05152 | 2.16865774 |
13 | * Osteoclast differentiation_Homo sapiens_hsa04380 | 2.16631418 |
14 | Phagosome_Homo sapiens_hsa04145 | 2.09783918 |
15 | Pertussis_Homo sapiens_hsa05133 | 2.06427300 |
16 | NF-kappa B signaling pathway_Homo sapiens_hsa04064 | 1.94240407 |
17 | Glycosaminoglycan biosynthesis - chondroitin sulfate / dermatan sulfate_Homo sapiens_hsa00532 | 1.82037650 |
18 | NOD-like receptor signaling pathway_Homo sapiens_hsa04621 | 1.79936396 |
19 | Allograft rejection_Homo sapiens_hsa05330 | 1.79051248 |
20 | Salmonella infection_Homo sapiens_hsa05132 | 1.71242010 |
21 | Measles_Homo sapiens_hsa05162 | 1.69591001 |
22 | ECM-receptor interaction_Homo sapiens_hsa04512 | 1.62742795 |
23 | Cytosolic DNA-sensing pathway_Homo sapiens_hsa04623 | 1.58824337 |
24 | Other glycan degradation_Homo sapiens_hsa00511 | 1.58160175 |
25 | Glutathione metabolism_Homo sapiens_hsa00480 | 1.56442742 |
26 | Asthma_Homo sapiens_hsa05310 | 1.56098457 |
27 | Viral myocarditis_Homo sapiens_hsa05416 | 1.46307230 |
28 | TNF signaling pathway_Homo sapiens_hsa04668 | 1.45886718 |
29 | RIG-I-like receptor signaling pathway_Homo sapiens_hsa04622 | 1.45746461 |
30 | Inflammatory bowel disease (IBD)_Homo sapiens_hsa05321 | 1.45335557 |
31 | Butirosin and neomycin biosynthesis_Homo sapiens_hsa00524 | 1.44885768 |
32 | Primary bile acid biosynthesis_Homo sapiens_hsa00120 | 1.42104592 |
33 | Toxoplasmosis_Homo sapiens_hsa05145 | 1.41462612 |
34 | Influenza A_Homo sapiens_hsa05164 | 1.41225764 |
35 | Epithelial cell signaling in Helicobacter pylori infection_Homo sapiens_hsa05120 | 1.39175309 |
36 | PPAR signaling pathway_Homo sapiens_hsa03320 | 1.36870246 |
37 | Phenylalanine, tyrosine and tryptophan biosynthesis_Homo sapiens_hsa00400 | 1.36393988 |
38 | Bacterial invasion of epithelial cells_Homo sapiens_hsa05100 | 1.31120006 |
39 | Nicotinate and nicotinamide metabolism_Homo sapiens_hsa00760 | 1.24337493 |
40 | Type I diabetes mellitus_Homo sapiens_hsa04940 | 1.20980380 |
41 | B cell receptor signaling pathway_Homo sapiens_hsa04662 | 1.20645213 |
42 | Glycosphingolipid biosynthesis - ganglio series_Homo sapiens_hsa00604 | 1.20345386 |
43 | Ubiquinone and other terpenoid-quinone biosynthesis_Homo sapiens_hsa00130 | 1.19442745 |
44 | Circadian rhythm_Homo sapiens_hsa04710 | 1.17628949 |
45 | Chagas disease (American trypanosomiasis)_Homo sapiens_hsa05142 | 1.16740524 |
46 | Collecting duct acid secretion_Homo sapiens_hsa04966 | 1.16122944 |
47 | Fatty acid elongation_Homo sapiens_hsa00062 | 1.15964534 |
48 | Cytokine-cytokine receptor interaction_Homo sapiens_hsa04060 | 1.13638099 |
49 | Hypertrophic cardiomyopathy (HCM)_Homo sapiens_hsa05410 | 1.13106017 |
50 | 2-Oxocarboxylic acid metabolism_Homo sapiens_hsa01210 | 1.11837461 |
51 | Fructose and mannose metabolism_Homo sapiens_hsa00051 | 1.09811130 |
52 | Fc gamma R-mediated phagocytosis_Homo sapiens_hsa04666 | 1.08942731 |
53 | Apoptosis_Homo sapiens_hsa04210 | 1.06462085 |
54 | Amoebiasis_Homo sapiens_hsa05146 | 1.05224196 |
55 | Carbon metabolism_Homo sapiens_hsa01200 | 1.04733666 |
56 | Hematopoietic cell lineage_Homo sapiens_hsa04640 | 1.02250145 |
57 | Dilated cardiomyopathy_Homo sapiens_hsa05414 | 1.01871017 |
58 | Sulfur metabolism_Homo sapiens_hsa00920 | 1.00936607 |
59 | Chemokine signaling pathway_Homo sapiens_hsa04062 | 1.00841887 |
60 | African trypanosomiasis_Homo sapiens_hsa05143 | 0.97120134 |
61 | HIF-1 signaling pathway_Homo sapiens_hsa04066 | 0.96744133 |
62 | cGMP-PKG signaling pathway_Homo sapiens_hsa04022 | 0.94945757 |
63 | Renal cell carcinoma_Homo sapiens_hsa05211 | 0.93793241 |
64 | Herpes simplex infection_Homo sapiens_hsa05168 | 0.92637852 |
65 | Leukocyte transendothelial migration_Homo sapiens_hsa04670 | 0.90256842 |
66 | Shigellosis_Homo sapiens_hsa05131 | 0.89729779 |
67 | ABC transporters_Homo sapiens_hsa02010 | 0.88864970 |
68 | Intestinal immune network for IgA production_Homo sapiens_hsa04672 | 0.88571461 |
69 | Propanoate metabolism_Homo sapiens_hsa00640 | 0.87385355 |
70 | Galactose metabolism_Homo sapiens_hsa00052 | 0.86792306 |
71 | Glycosphingolipid biosynthesis - globo series_Homo sapiens_hsa00603 | 0.86409271 |
72 | Natural killer cell mediated cytotoxicity_Homo sapiens_hsa04650 | 0.84777242 |
73 | Hepatitis B_Homo sapiens_hsa05161 | 0.84714717 |
74 | Vascular smooth muscle contraction_Homo sapiens_hsa04270 | 0.83353553 |
75 | AGE-RAGE signaling pathway in diabetic complications_Homo sapiens_hsa04933 | 0.83158223 |
76 | Nitrogen metabolism_Homo sapiens_hsa00910 | 0.80106949 |
77 | Adipocytokine signaling pathway_Homo sapiens_hsa04920 | 0.80056741 |
78 | Complement and coagulation cascades_Homo sapiens_hsa04610 | 0.78927958 |
79 | Pyruvate metabolism_Homo sapiens_hsa00620 | 0.77877927 |
80 | Autoimmune thyroid disease_Homo sapiens_hsa05320 | 0.77357500 |
81 | Jak-STAT signaling pathway_Homo sapiens_hsa04630 | 0.77110385 |
82 | Central carbon metabolism in cancer_Homo sapiens_hsa05230 | 0.76004402 |
83 | Adherens junction_Homo sapiens_hsa04520 | 0.73484669 |
84 | Insulin signaling pathway_Homo sapiens_hsa04910 | 0.73464340 |
85 | Hepatitis C_Homo sapiens_hsa05160 | 0.72157991 |
86 | Sphingolipid metabolism_Homo sapiens_hsa00600 | 0.71107203 |
87 | Non-alcoholic fatty liver disease (NAFLD)_Homo sapiens_hsa04932 | 0.69629011 |
88 | SNARE interactions in vesicular transport_Homo sapiens_hsa04130 | 0.69448674 |
89 | Prion diseases_Homo sapiens_hsa05020 | 0.67731824 |
90 | Inositol phosphate metabolism_Homo sapiens_hsa00562 | 0.65017250 |
91 | Focal adhesion_Homo sapiens_hsa04510 | 0.64878675 |
92 | Calcium signaling pathway_Homo sapiens_hsa04020 | 0.64404544 |
93 | Proteoglycans in cancer_Homo sapiens_hsa05205 | 0.63544379 |
94 | Fc epsilon RI signaling pathway_Homo sapiens_hsa04664 | 0.63258636 |
95 | Citrate cycle (TCA cycle)_Homo sapiens_hsa00020 | 0.62287098 |
96 | Regulation of actin cytoskeleton_Homo sapiens_hsa04810 | 0.58898946 |
97 | Platelet activation_Homo sapiens_hsa04611 | 0.58473559 |
98 | Starch and sucrose metabolism_Homo sapiens_hsa00500 | 0.57991167 |
99 | Chronic myeloid leukemia_Homo sapiens_hsa05220 | 0.57208442 |
100 | Fatty acid degradation_Homo sapiens_hsa00071 | 0.57025059 |
101 | Steroid biosynthesis_Homo sapiens_hsa00100 | 0.56546159 |
102 | Prostate cancer_Homo sapiens_hsa05215 | 0.56182405 |
103 | Cardiac muscle contraction_Homo sapiens_hsa04260 | 0.55370211 |
104 | Ovarian steroidogenesis_Homo sapiens_hsa04913 | 0.53718142 |
105 | Histidine metabolism_Homo sapiens_hsa00340 | 0.52967752 |
106 | Vibrio cholerae infection_Homo sapiens_hsa05110 | 0.50948276 |
107 | Small cell lung cancer_Homo sapiens_hsa05222 | 0.50667239 |
108 | Sphingolipid signaling pathway_Homo sapiens_hsa04071 | 0.50128538 |
109 | Antigen processing and presentation_Homo sapiens_hsa04612 | 0.48087428 |
110 | Acute myeloid leukemia_Homo sapiens_hsa05221 | 0.47874440 |
111 | beta-Alanine metabolism_Homo sapiens_hsa00410 | 0.47765260 |
112 | Oxidative phosphorylation_Homo sapiens_hsa00190 | 0.46728041 |
113 | * Melanogenesis_Homo sapiens_hsa04916 | 0.46582068 |
114 | Tight junction_Homo sapiens_hsa04530 | 0.45427564 |
115 | Dorso-ventral axis formation_Homo sapiens_hsa04320 | 0.45342662 |
116 | Insulin resistance_Homo sapiens_hsa04931 | 0.44708437 |
117 | Neurotrophin signaling pathway_Homo sapiens_hsa04722 | 0.44606712 |
118 | Pancreatic cancer_Homo sapiens_hsa05212 | 0.44220623 |
119 | Mineral absorption_Homo sapiens_hsa04978 | 0.42656391 |
120 | Pathogenic Escherichia coli infection_Homo sapiens_hsa05130 | 0.42220380 |
121 | Fatty acid metabolism_Homo sapiens_hsa01212 | 0.41542973 |
122 | Phospholipase D signaling pathway_Homo sapiens_hsa04072 | 0.39469875 |
123 | Bladder cancer_Homo sapiens_hsa05219 | 0.39245797 |
124 | Thyroid hormone signaling pathway_Homo sapiens_hsa04919 | 0.39070600 |
125 | N-Glycan biosynthesis_Homo sapiens_hsa00510 | 0.38713851 |
126 | Arginine and proline metabolism_Homo sapiens_hsa00330 | 0.38063611 |
127 | Ether lipid metabolism_Homo sapiens_hsa00565 | 0.38020530 |
128 | Adrenergic signaling in cardiomyocytes_Homo sapiens_hsa04261 | 0.37245897 |
129 | Endocytosis_Homo sapiens_hsa04144 | 0.35975514 |
130 | Cysteine and methionine metabolism_Homo sapiens_hsa00270 | 0.34685671 |
131 | Phosphatidylinositol signaling system_Homo sapiens_hsa04070 | 0.34623121 |
132 | Type II diabetes mellitus_Homo sapiens_hsa04930 | 0.34596397 |
133 | FoxO signaling pathway_Homo sapiens_hsa04068 | 0.34468874 |
134 | Prolactin signaling pathway_Homo sapiens_hsa04917 | 0.34227467 |
135 | Arrhythmogenic right ventricular cardiomyopathy (ARVC)_Homo sapiens_hsa05412 | 0.33234109 |
136 | Amino sugar and nucleotide sugar metabolism_Homo sapiens_hsa00520 | 0.32358956 |
137 | MicroRNAs in cancer_Homo sapiens_hsa05206 | 0.31281399 |
138 | AMPK signaling pathway_Homo sapiens_hsa04152 | 0.31197242 |
139 | Alzheimers disease_Homo sapiens_hsa05010 | 0.29840074 |
140 | Thyroid cancer_Homo sapiens_hsa05216 | 0.29266292 |
141 | Pentose and glucuronate interconversions_Homo sapiens_hsa00040 | 0.29063888 |
142 | Lysine degradation_Homo sapiens_hsa00310 | 0.28657133 |
143 | Glycolysis / Gluconeogenesis_Homo sapiens_hsa00010 | 0.28529007 |
144 | Oxytocin signaling pathway_Homo sapiens_hsa04921 | 0.28516523 |
145 | Viral carcinogenesis_Homo sapiens_hsa05203 | 0.28016457 |
146 | Regulation of lipolysis in adipocytes_Homo sapiens_hsa04923 | 0.27669844 |
147 | Glioma_Homo sapiens_hsa05214 | 0.26811922 |
148 | Endometrial cancer_Homo sapiens_hsa05213 | 0.25551589 |
149 | Non-small cell lung cancer_Homo sapiens_hsa05223 | 0.23542116 |